Editorial: Flavonoids and Cardiovascular Metabolism

Editorial: Flavonoids and Cardiovascular Metabolism

Bibliographic Details
Main Authors:	Qiao Zhang, Shi-Jun Yue
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Nutrition
Subjects:	flavonoid cardiovascular diseases inflammation oxidative stress gut microbiota
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2022.939798/full

Similar Items

Editorial: Advances in targeted delivery of natural flavonoids
by: Yang Xu, et al.
Published: (2023-08-01)

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids
by: Qinyu Li, et al.
Published: (2021-06-01)

Editorial: Flavonoids and chronic metabolic diseases
by: Qian Zhou, et al.
Published: (2024-04-01)

Anti-fatigue activity of parsley (Petroselinum crispum) flavonoids via regulation of oxidative stress and gut microbiota in mice
by: Yu Wang, et al.
Published: (2022-02-01)

Editorial: Immune Modulation by Flavonoids
by: David W. Hoskin, et al.
Published: (2022-04-01)

The Effects of Flavonoids in Cardiovascular Diseases
by: Lorena Ciumărnean, et al.
Published: (2020-09-01)

Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases
by: Ting-Wei Kao, et al.
Published: (2022-01-01)

The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
by: Richard Y. Cao, et al.
Published: (2021-12-01)

The Interaction between Flavonoids and Intestinal Microbes: A Review
by: Hui-Hui Xiong, et al.
Published: (2023-01-01)

Flavonoids in Treatment of Chronic Kidney Disease
by: Yi-Ling Cao, et al.
Published: (2022-04-01)

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
by: Ganesan Velmurugan, et al.
Published: (2022-12-01)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
by: Antje R. Weseler, et al.
Published: (2023-05-01)

Limosilactobacillus reuteri DSM 17938 reverses gut metabolic dysfunction induced by Western diet in adult rats
by: Jumana Abuqwider, et al.
Published: (2023-10-01)

Vitamins, Minerals and Flavonoids Intake and the Risk of Cardiovascular Diseases
by: Shiva Tabatabai, et al.
Published: (2007-01-01)

Vitamins, Minerals and Flavonoids Intake and the Risk of Cardiovascular Diseases
by: Seyed Ali Keshavarz, et al.
Published: (2007-06-01)

Endoplasmic reticulum as a target in cardiovascular diseases: Is there a role for flavonoids?
by: Kimia Keylani, et al.
Published: (2023-01-01)

(Poly)phenols and the regulation of NADPH oxidases
by: Cesar G. Fraga, et al.
Published: (2023-11-01)

Editorial: Probiotics for nutrition research in health and disease
by: José Luiz de Brito Alves, et al.
Published: (2023-06-01)

The Potential Role of Phytonutrients Flavonoids Influencing Gut Microbiota in the Prophylaxis and Treatment of Inflammatory Bowel Disease
by: Lina Wang, et al.
Published: (2021-12-01)

Flavonoids and Colorectal Cancer Prevention
by: Yanyan Li, et al.
Published: (2018-12-01)

Osteoarthritis in the Elderly Population: Preclinical Evidence of Nutrigenomic Activities of Flavonoids
by: Flores Naselli, et al.
Published: (2023-12-01)

Citrus flavonoids and adhesion molecules: Potential role in the management of atherosclerosis
by: Farnaz Ebrahimi, et al.
Published: (2023-11-01)

An Integrative Approach to Characterize the Early Phases of Dimethylhydrazine-Induced Colorectal Carcinogenesis in the Rat
by: Rita Silva-Reis, et al.
Published: (2022-02-01)

Flavonoids Regulate Inflammation and Oxidative Stress in Cancer
by: Guangxing Li, et al.
Published: (2020-11-01)

The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review
by: Rosa Savino, et al.
Published: (2023-05-01)

The Benefits of Flavonoids in Diabetic Retinopathy
by: Ana L. Matos, et al.
Published: (2020-10-01)

Editorial: Effects of medicinal homologous foods on immunity through intestinal flora
by: Zhoujin Tan, et al.
Published: (2024-01-01)

The neuromodulatory effects of flavonoids and gut Microbiota through the gut-brain axis
by: Haoran Wang, et al.
Published: (2023-06-01)

Gut Microbiota and Its Implications for Cardiovascular Diseases – a Review
by: Julia Zarębska, et al.
Published: (2024-02-01)

Flavonoids-Macromolecules Interactions in Human Diseases with Focus on Alzheimer, Atherosclerosis and Cancer
by: Dana Atrahimovich, et al.
Published: (2021-03-01)

The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases
by: Ruxandra Florentina Ionescu, et al.
Published: (2022-03-01)

Total Flavonoids of Glycyrrhiza uralensis Alleviates Irinotecan-Induced Colitis via Modification of Gut Microbiota and Fecal Metabolism
by: Shi-Jun Yue, et al.
Published: (2021-05-01)

Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship
by: Antonio Nesci, et al.
Published: (2023-05-01)

Date Palm Fruit (<i>Phoenix dactylifera</i>): Effects on Vascular Health and Future Research Directions
by: Yousef A. Al-Dashti, et al.
Published: (2021-04-01)

Gut microbiota derived metabolites in cardiovascular health and disease
by: Zeneng Wang, et al.
Published: (2018-05-01)

The great potential of flavonoids as candidate drugs for NAFLD
by: Liangge Li, et al.
Published: (2023-08-01)

Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer’s disease progression
by: Tushar K. Das, et al.
Published: (2023-12-01)

Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
by: Junwen Zhu, et al.
Published: (2023-09-01)

Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota
by: Qi-You Ding, et al.
Published: (2020-10-01)

The protective effects of flavonoids and carotenoids against diabetic complications—A review of in vivo evidence
by: Yannan Jin, et al.
Published: (2023-03-01)